Health
AstraZeneca denies vaccine trial subject had nerve ailment – The Peninsula Qatar
Trials of the Oxford-Astra vaccine resumed in the U.K. over the weekend, after a pause to investigate the adverse event, while researchers in South Africa also restarted tests.
AstraZeneca Plc, the drugmaker working with the University of Oxford on a Covid-19 vaccine, contradicted a report that a volunteer in U.K. tests of the shot developed a rare nerve disease that might have signaled severe safety problems.
AstraZeneca was responding Thursday to a CNN report citing documents indicating that the diagnosis of the participant was confirmed as transverse myelitis. The diagnosis was “based on preliminary findings,” and is inaccurate, the Cambridge, England-based drugmak…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General15 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General14 hours agoOf saints and sinners | The Spectator Australia